Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ESMO 2020
Biotech
Seattle Genetics' ADC curbs hard-to-treat cervical cancer
Seattle Genetics and Genmab’s antibody-drug conjugate shrank tumors in 24% of patients with cervical cancer, stopping tumor growth in half of them.
Amirah Al Idrus
Sep 21, 2020 10:20am
ESMO: Blueprint preps trial of drug for triple-mutant NSCLC
Sep 21, 2020 9:25am
Adding Elevar's EGFR drug to Iressa boosts lung cancer survival
Sep 21, 2020 8:40am
ESMO: Early days, but Amgen's BiTE drug shows promise
Sep 21, 2020 8:25am
ESMO: Roche's Akt inhibitor scores slight win over J&J's Zytiga
Sep 20, 2020 1:02pm
J&J's anti-EGFR combo tackles NSCLC ahead of Tagrisso showdown
Sep 20, 2020 8:37am
